1h Free Analyst Time
The blood glucose monitoring devices market is forecasted to grow by USD 8.70 billion during 2023-2028, accelerating at a CAGR of 9.45% during the forecast period. The report on the blood glucose monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global burden of diabetes, technological advances in blood glucose monitoring devices, and availability of reimbursement for blood glucose monitoring devices.
The blood glucose monitoring devices market is segmented as below:
By End-user
- Hospitals
- Home care
- Diagnostic centers
By Product
- SMBG
- CGM
- Lancets
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the blood glucose monitoring devices market covers the following areas:
- Blood glucose monitoring devices market sizing
- Blood glucose monitoring devices market forecast
- Blood glucose monitoring devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global blood glucose monitoring devices market: Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Bigfoot Biomedical Inc., Dexcom Inc., DiaMonTech AG, F. Hoffmann La Roche Ltd., GlySens Inc., Health Arx Technologies Pvt. Ltd., Insulet Corp., Level2 Medical Services P.A., Levels Health Inc., Medtronic Plc, Medtrum Technologies Inc., Novo Nordisk AS, PKvitality S.A.S., Sanofi SA, Senseonics Holdings Inc., SFC Fluidics Inc., Teladoc Health Inc., and Ypsomed Holding AG.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is smart watch-based apps."
According to the report, one of the major drivers for this market is the rising global burden of diabetes.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Ascensia Diabetes Care Holdings AG
- Bigfoot Biomedical Inc.
- Dexcom Inc.
- DiaMonTech AG
- F. Hoffmann La Roche Ltd.
- GlySens Inc.
- Health Arx Technologies Pvt. Ltd.
- Insulet Corp.
- Level2 Medical Services P.A.
- Levels Health Inc.
- Medtronic Plc
- Medtrum Technologies Inc.
- Novo Nordisk AS
- PKvitality S.A.S.
- Sanofi SA
- Senseonics Holdings Inc.
- SFC Fluidics Inc.
- Teladoc Health Inc.
- Ypsomed Holding AG
